The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Clonal evolution of uveal melanoma metastases.
 
Jessica Yang
No Relationships to Disclose
 
Heather M. Geiger
No Relationships to Disclose
 
Junfei Zhao
No Relationships to Disclose
 
James C. Chen
No Relationships to Disclose
 
Kanika Arora
No Relationships to Disclose
 
Minita Shah
No Relationships to Disclose
 
Armida Fabius
No Relationships to Disclose
 
Magali Cavatore
No Relationships to Disclose
 
Cyriac Kandoth
No Relationships to Disclose
 
Taha Merghoub
No Relationships to Disclose
 
Jacob Lowell Glass
No Relationships to Disclose
 
Grazia Ambrosini
No Relationships to Disclose
 
Kimberly Mayumi Komatsubara
Consulting or Advisory Role - Roche
 
Gary K. Schwartz
Honoraria - BioMotiv; Bionaut Labs; Champions Oncology; Daiichi Sankyo; DarwinHealth; Human Longevity, Inc; Karyopharm Therapeutics
Consulting or Advisory Role - BioMotiv; Bionaut Labs; Champions Oncology; Daiichi Sankyo; DarwinHealth; Human Longevity, Inc; Karyopharm Therapeutics; PureTech
Research Funding - Astex Pharmaceuticals
Patents, Royalties, Other Intellectual Property - Patent pending regarding development of PNAs for targeted cancer therapy (new technology)
Travel, Accommodations, Expenses - Daiichi Sankyo
 
Raul Rabadan
No Relationships to Disclose
 
Nicolas Robine
No Relationships to Disclose
 
Alexander Noor Shoushtari
Consulting or Advisory Role - Castle Biosciences; Immunocore
Research Funding - Bristol-Myers Squibb; Immunocore; Xcovery
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Richard D. Carvajal
Consulting or Advisory Role - AstraZeneca; Aura Biosciences; Bristol-Myers Squibb; Castle Biosciences; Genentech/Roche; Iconic Therapeutics; Janssen Oncology; Merck; Novartis